Johnson & Johnson readies hit list By Cathy Taylor and Michael McCarth

NEW YORK--Executives at Johnson & Johnson agencies were on pins and needles last week, awaiting the final word on a long-anticipated global re

When it comes down, sources said, it will delineate who the favored sons are on the New Brunswick, N.J.-based client’s long roster. “It will be similar to what P&G and Unilever have done recently,” said one source.
However, some sources speculate that a new shop might pop up on the roster to handle Pepcid anti-ulcer drug, which is currently prescription only.
Exactly which brands will move has not been finalized, but agency executives said that Young & Rubicam and Cadwell Davis Partners will probably see their role on the agency roster diminished, if not broken off entirely.